McKesson Corporation Logo

McKesson Corporation

MCK

(2.2)
Stock Price

508,16 USD

6.46% ROA

-163.38% ROE

18.73x PER

Market Cap.

64.833.128.880,00 USD

-400.22% DER

0.48% Yield

0.99% NPM

McKesson Corporation Stock Analysis

McKesson Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

McKesson Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROE

The stock's ROE exceeds expectations (1473.28%), revealing strong profitability and efficient use of shareholders' equity, making it an attractive investment opportunity.

2 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 Dividend Growth

With a history of consistent dividend increases over the last five years, the company has proven to be a reliable choice for investors seeking steady income.

4 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

5 ROA

The stock's ROA (6.46%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 PBV

The stock's high Price-to-Book Value (P/BV) ratio (8.8x) suggests it's overvalued, potentially making it an expensive investment.

7 DER

The company has a high debt to equity ratio (107%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

8 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

The Graham number of this company suggests that its stock price may be overvalued, indicating a less favorable investment opportunity.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (-13.762) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

McKesson Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

McKesson Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Buy
4 Stoch RSI Sell

McKesson Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

McKesson Corporation Revenue
Year Revenue Growth
1995 13.189.100.000
1996 13.716.400.000 3.84%
1997 12.886.700.000 -6.44%
1998 20.857.300.000 38.21%
1999 30.382.300.000 31.35%
2000 36.734.200.000 17.29%
2001 42.010.000.000 12.56%
2002 50.006.000.000 15.99%
2003 57.120.800.000 12.46%
2004 69.506.100.000 17.82%
2005 80.514.600.000 13.67%
2006 88.050.000.000 8.56%
2007 92.977.000.000 5.3%
2008 101.703.000.000 8.58%
2009 106.632.000.000 4.62%
2010 108.702.000.000 1.9%
2011 112.084.000.000 3.02%
2012 122.734.000.000 8.68%
2013 122.455.000.000 -0.23%
2014 137.609.000.000 11.01%
2015 179.045.000.000 23.14%
2016 190.884.000.000 6.2%
2017 198.533.000.000 3.85%
2018 208.357.000.000 4.71%
2019 214.319.000.000 2.78%
2020 231.051.000.000 7.24%
2021 238.228.000.000 3.01%
2022 263.966.000.000 9.75%
2023 276.711.000.000 4.61%
2024 308.860.000.000 10.41%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

McKesson Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1995 0
1996 0 0%
1997 0 0%
1998 0 0%
1999 114.700.000 100%
2000 112.600.000 -1.87%
2001 147.500.000 23.66%
2002 135.100.000 -9.18%
2003 149.400.000 9.57%
2004 172.700.000 13.49%
2005 182.000.000 5.11%
2006 223.000.000 18.39%
2007 284.000.000 21.48%
2008 347.000.000 18.16%
2009 364.000.000 4.67%
2010 376.000.000 3.19%
2011 407.000.000 7.62%
2012 440.000.000 7.5%
2013 480.000.000 8.33%
2014 456.000.000 -5.26%
2015 392.000.000 -16.33%
2016 392.000.000 0%
2017 341.000.000 -14.96%
2018 125.000.000 -172.8%
2019 71.000.000 -76.06%
2020 96.000.000 26.04%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

McKesson Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1995 1.124.000.000
1996 872.900.000 -28.77%
1997 944.500.000 7.58%
1998 1.159.100.000 18.51%
1999 2.218.700.000 47.76%
2000 2.051.600.000 -8.14%
2001 2.075.500.000 1.15%
2002 1.946.200.000 -6.64%
2003 2.023.200.000 3.81%
2004 2.092.100.000 3.29%
2005 2.273.200.000 7.97%
2006 2.480.000.000 8.34%
2007 2.790.000.000 11.11%
2008 3.189.000.000 12.51%
2009 3.075.000.000 -3.71%
2010 2.566.000.000 -19.84%
2011 2.762.000.000 7.1%
2012 3.065.000.000 9.89%
2013 2.351.000.000 -30.37%
2014 5.418.000.000 56.61%
2015 7.901.000.000 31.43%
2016 7.276.000.000 -8.59%
2017 7.466.000.000 2.54%
2018 8.138.000.000 8.26%
2019 8.403.000.000 3.15%
2020 18.336.000.000 54.17%
2021 17.698.000.000 -3.6%
2022 21.074.000.000 16.02%
2023 15.552.000.000 -35.51%
2024 16.736.000.000 7.07%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

McKesson Corporation EBITDA
Year EBITDA Growth
1995 34.300.000
1996 345.400.000 90.07%
1997 164.600.000 -109.84%
1998 449.400.000 63.37%
1999 531.500.000 15.45%
2000 90.400.000 -487.94%
2001 423.100.000 78.63%
2002 896.400.000 52.8%
2003 1.087.100.000 17.54%
2004 1.167.300.000 6.87%
2005 1.191.700.000 2.05%
2006 1.287.000.000 7.4%
2007 1.547.000.000 16.81%
2008 1.833.000.000 15.6%
2009 1.637.000.000 -11.97%
2010 2.482.000.000 34.05%
2011 2.530.000.000 1.9%
2012 2.700.000.000 6.3%
2013 2.929.000.000 7.82%
2014 3.171.000.000 7.63%
2015 4.198.000.000 24.46%
2016 4.691.000.000 10.51%
2017 4.470.000.000 -4.94%
2018 3.754.000.000 -19.07%
2019 4.217.000.000 10.98%
2020 2.585.000.000 -63.13%
2021 4.409.000.000 41.37%
2022 3.612.000.000 -22.07%
2023 5.687.000.000 36.49%
2024 4.012.000.000 -41.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

McKesson Corporation Gross Profit
Year Gross Profit Growth
1995 1.163.700.000
1996 1.218.300.000 4.48%
1997 1.109.100.000 -9.85%
1998 1.608.500.000 31.05%
1999 2.864.900.000 43.85%
2000 2.523.700.000 -13.52%
2001 2.431.000.000 -3.81%
2002 2.796.900.000 13.08%
2003 3.102.500.000 9.85%
2004 3.248.200.000 4.49%
2005 3.464.700.000 6.25%
2006 3.862.000.000 10.29%
2007 4.332.000.000 10.85%
2008 5.009.000.000 13.52%
2009 5.378.000.000 6.86%
2010 5.676.000.000 5.25%
2011 5.970.000.000 4.92%
2012 6.567.000.000 9.09%
2013 6.984.000.000 5.97%
2014 8.309.000.000 15.95%
2015 11.411.000.000 27.18%
2016 11.416.000.000 0.04%
2017 11.271.000.000 -1.29%
2018 11.184.000.000 -0.78%
2019 11.754.000.000 4.85%
2020 12.023.000.000 2.24%
2021 12.148.000.000 1.03%
2022 13.130.000.000 7.48%
2023 12.358.000.000 -6.25%
2024 12.276.000.000 -0.67%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

McKesson Corporation Net Profit
Year Net Profit Growth
1995 404.500.000
1996 135.400.000 -198.74%
1997 133.900.000 -1.12%
1998 154.900.000 13.56%
1999 84.900.000 -82.45%
2000 723.700.000 88.27%
2001 -48.300.000 1598.34%
2002 418.600.000 111.54%
2003 555.400.000 24.63%
2004 646.500.000 14.09%
2005 -156.700.000 512.57%
2006 751.000.000 120.87%
2007 913.000.000 17.74%
2008 990.000.000 7.78%
2009 823.000.000 -20.29%
2010 1.263.000.000 34.84%
2011 1.202.000.000 -5.07%
2012 1.403.000.000 14.33%
2013 1.338.000.000 -4.86%
2014 1.263.000.000 -5.94%
2015 1.476.000.000 14.43%
2016 2.258.000.000 34.63%
2017 5.070.000.000 55.46%
2018 67.000.000 -7467.16%
2019 34.000.000 -97.06%
2020 900.000.000 96.22%
2021 -4.339.000.000 120.74%
2022 1.114.000.000 489.5%
2023 3.560.000.000 68.71%
2024 2.656.000.000 -34.04%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

McKesson Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1995 5
1996 2 -300%
1997 1 0%
1998 1 100%
1999 0 0%
2000 3 100%
2001 0 0%
2002 1 100%
2003 2 0%
2004 2 50%
2005 -1 0%
2006 2 100%
2007 3 33.33%
2008 3 0%
2009 3 -50%
2010 5 50%
2011 5 0%
2012 6 20%
2013 6 0%
2014 6 0%
2015 6 16.67%
2016 10 33.33%
2017 23 59.09%
2018 0 0%
2019 0 0%
2020 5 100%
2021 -27 114.81%
2022 7 485.71%
2023 25 72%
2024 20 -31.58%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

McKesson Corporation Free Cashflow
Year Free Cashflow Growth
1995 112.800.000
1996 -108.300.000 204.16%
1997 -1.048.300.000 89.67%
1998 -230.200.000 -355.39%
1999 -236.300.000 2.58%
2000 -561.100.000 57.89%
2001 194.200.000 388.93%
2002 197.500.000 1.67%
2003 579.500.000 65.92%
2004 448.400.000 -29.24%
2005 1.398.500.000 67.94%
2006 2.577.000.000 45.73%
2007 1.233.000.000 -109%
2008 513.000.000 -140.35%
2009 959.000.000 46.51%
2010 1.938.000.000 50.52%
2011 1.950.000.000 0.62%
2012 2.547.000.000 23.44%
2013 2.077.000.000 -22.63%
2014 2.721.000.000 23.67%
2015 2.567.000.000 -6%
2016 2.995.000.000 14.29%
2017 4.182.000.000 28.38%
2018 3.765.000.000 -11.08%
2019 3.479.000.000 -8.22%
2020 3.868.000.000 10.06%
2021 3.901.000.000 0.85%
2022 3.899.000.000 -0.05%
2023 4.601.000.000 15.26%
2024 825.000.000 -457.7%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

McKesson Corporation Operating Cashflow
Year Operating Cashflow Growth
1995 195.100.000
1996 2.500.000 -7704%
1997 238.100.000 98.95%
1998 2.200.000 -10722.73%
1999 317.100.000 99.31%
2000 -416.000.000 176.23%
2001 353.100.000 217.81%
2002 329.300.000 -7.23%
2003 695.500.000 52.65%
2004 563.400.000 -23.45%
2005 1.538.400.000 63.38%
2006 2.744.000.000 43.94%
2007 1.539.000.000 -78.3%
2008 869.000.000 -77.1%
2009 1.351.000.000 35.68%
2010 2.316.000.000 41.67%
2011 2.338.000.000 0.94%
2012 2.950.000.000 20.75%
2013 2.483.000.000 -18.81%
2014 3.136.000.000 20.82%
2015 3.112.000.000 -0.77%
2016 3.672.000.000 15.25%
2017 4.744.000.000 22.6%
2018 4.345.000.000 -9.18%
2019 4.036.000.000 -7.66%
2020 4.374.000.000 7.73%
2021 4.542.000.000 3.7%
2022 4.434.000.000 -2.44%
2023 5.159.000.000 14.05%
2024 965.000.000 -434.61%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

McKesson Corporation Capital Expenditure
Year Capital Expenditure Growth
1995 82.300.000
1996 110.800.000 25.72%
1997 1.286.400.000 91.39%
1998 232.400.000 -453.53%
1999 553.400.000 58.01%
2000 145.100.000 -281.39%
2001 158.900.000 8.68%
2002 131.800.000 -20.56%
2003 116.000.000 -13.62%
2004 115.000.000 -0.87%
2005 139.900.000 17.8%
2006 167.000.000 16.23%
2007 306.000.000 45.42%
2008 356.000.000 14.04%
2009 392.000.000 9.18%
2010 378.000.000 -3.7%
2011 388.000.000 2.58%
2012 403.000.000 3.72%
2013 406.000.000 0.74%
2014 415.000.000 2.17%
2015 545.000.000 23.85%
2016 677.000.000 19.5%
2017 562.000.000 -20.46%
2018 580.000.000 3.1%
2019 557.000.000 -4.13%
2020 506.000.000 -10.08%
2021 641.000.000 21.06%
2022 535.000.000 -19.81%
2023 558.000.000 4.12%
2024 140.000.000 -298.57%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

McKesson Corporation Equity
Year Equity Growth
1995 1.013.500.000
1996 1.064.600.000 4.8%
1997 1.260.800.000 15.56%
1998 1.406.800.000 10.38%
1999 2.881.800.000 51.18%
2000 3.565.800.000 19.18%
2001 3.492.900.000 -2.09%
2002 3.940.100.000 11.35%
2003 4.528.500.000 12.99%
2004 5.165.300.000 12.33%
2005 5.275.100.000 2.08%
2006 5.907.000.000 10.7%
2007 6.273.000.000 5.83%
2008 6.121.000.000 -2.48%
2009 6.193.000.000 1.16%
2010 7.532.000.000 17.78%
2011 7.220.000.000 -4.32%
2012 6.831.000.000 -5.69%
2013 7.070.000.000 3.38%
2014 8.522.000.000 17.04%
2015 8.001.000.000 -6.51%
2016 8.924.000.000 10.34%
2017 11.095.000.000 19.57%
2018 9.804.000.000 -13.17%
2019 9.680.000.000 -1.28%
2020 6.711.000.000 -44.24%
2021 1.446.000.000 -364.11%
2022 -1.792.000.000 180.69%
2023 -1.490.000.000 -20.27%
2024 -1.464.000.000 -1.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

McKesson Corporation Assets
Year Assets Growth
1995 3.479.200.000
1996 3.503.900.000 0.7%
1997 5.172.800.000 32.26%
1998 5.607.500.000 7.75%
1999 9.081.600.000 38.25%
2000 10.372.900.000 12.45%
2001 11.529.900.000 10.03%
2002 13.324.000.000 13.47%
2003 14.353.400.000 7.17%
2004 16.240.200.000 11.62%
2005 18.775.000.000 13.5%
2006 20.975.000.000 10.49%
2007 23.943.000.000 12.4%
2008 24.603.000.000 2.68%
2009 25.267.000.000 2.63%
2010 28.189.000.000 10.37%
2011 30.886.000.000 8.73%
2012 33.093.000.000 6.67%
2013 34.786.000.000 4.87%
2014 51.759.000.000 32.79%
2015 53.870.000.000 3.92%
2016 56.563.000.000 4.76%
2017 60.969.000.000 7.23%
2018 60.381.000.000 -0.97%
2019 59.672.000.000 -1.19%
2020 61.247.000.000 2.57%
2021 65.015.000.000 5.8%
2022 63.298.000.000 -2.71%
2023 62.320.000.000 -1.57%
2024 66.091.000.000 5.71%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

McKesson Corporation Liabilities
Year Liabilities Growth
1995 2.405.800.000
1996 2.382.100.000 -0.99%
1997 3.717.200.000 35.92%
1998 4.005.300.000 7.19%
1999 6.004.200.000 33.29%
2000 6.611.300.000 9.18%
2001 7.841.100.000 15.68%
2002 9.187.800.000 14.66%
2003 9.628.600.000 4.58%
2004 11.074.900.000 13.06%
2005 13.499.900.000 17.96%
2006 15.068.000.000 10.41%
2007 17.670.000.000 14.73%
2008 18.482.000.000 4.39%
2009 19.074.000.000 3.1%
2010 20.657.000.000 7.66%
2011 23.666.000.000 12.71%
2012 26.262.000.000 9.89%
2013 27.716.000.000 5.25%
2014 41.441.000.000 33.12%
2015 44.399.000.000 6.66%
2016 46.149.000.000 3.79%
2017 48.369.000.000 4.59%
2018 48.865.000.000 1.02%
2019 49.992.000.000 2.25%
2020 54.536.000.000 8.33%
2021 63.569.000.000 14.21%
2022 65.090.000.000 2.34%
2023 63.810.000.000 -2.01%
2024 67.555.000.000 5.54%

McKesson Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2170.75
Net Income per Share
26.01
Price to Earning Ratio
18.73x
Price To Sales Ratio
0.22x
POCF Ratio
13.32
PFCF Ratio
15.06
Price to Book Ratio
-35.74
EV to Sales
0.24
EV Over EBITDA
13.04
EV to Operating CashFlow
14.19
EV to FreeCashFlow
16.17
Earnings Yield
0.05
FreeCashFlow Yield
0.07
Market Cap
64,83 Bil.
Enterprise Value
69,63 Bil.
Graham Number
89.32
Graham NetNet
-277.32

Income Statement Metrics

Net Income per Share
26.01
Income Quality
1.35
ROE
-1.8
Return On Assets
0.05
Return On Capital Employed
0.25
Net Income per EBT
0.84
EBT Per Ebit
0.97
Ebit per Revenue
0.01
Effective Tax Rate
0.11

Margins

Sales, General, & Administrative to Revenue
0.05
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.04
Operating Profit Margin
0.01
Pretax Profit Margin
0.01
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0.48
Payout Ratio
0.09
Dividend Per Share
2.32

Operating Metrics

Operating Cashflow per Share
36.58
Free CashFlow per Share
32.11
Capex to Operating CashFlow
-0.12
Capex to Revenue
-0
Capex to Depreciation
-0.96
Return on Invested Capital
0.49
Return on Tangible Assets
0.06
Days Sales Outstanding
28.2
Days Payables Outstanding
61.27
Days of Inventory on Hand
28.73
Receivables Turnover
12.94
Payables Turnover
5.96
Inventory Turnover
12.7
Capex per Share
-4.47

Balance Sheet

Cash per Share
18,82
Book Value per Share
-13,63
Tangible Book Value per Share
-100.97
Shareholders Equity per Share
-13.63
Interest Debt per Share
56.47
Debt to Equity
-4
Debt to Assets
0.11
Net Debt to EBITDA
0.9
Current Ratio
0.93
Tangible Asset Value
-13,54 Bil.
Net Current Asset Value
-20,02 Bil.
Invested Capital
-4
Working Capital
-3,62 Bil.
Intangibles to Total Assets
0.18
Average Receivables
22,18 Bil.
Average Payables
45,39 Bil.
Average Inventory
21227500000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

McKesson Corporation Dividends
Year Dividends Growth
1994 0
1995 1 0%
1996 1 100%
1997 1 0%
1998 1 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 1 0%
2011 1 0%
2012 1 0%
2013 1 0%
2014 1 0%
2015 1 100%
2016 1 0%
2017 1 0%
2018 1 0%
2019 2 0%
2020 2 0%
2021 2 0%
2022 2 50%
2023 2 0%

McKesson Corporation Profile

About McKesson Corporation

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

CEO
Mr. Brian S. Tyler Ph.D.
Employee
45.000
Address
6555 State Highway 161
Irving, 75039

McKesson Corporation Executives & BODs

McKesson Corporation Executives & BODs
# Name Age
1 Ms. Lori A. Schechter J.D.
Board & Enterprise Risk Advisor
70
2 Mr. Britt J. Vitalone
Executive Vice President & Chief Financial Officer
70
3 Mr. Napoleon B. Rutledge Jr.
Senior Vice President, Controller & Chief Accounting Officer
70
4 Mr. Francisco Fraga
Executive Vice President, Chief Information Officer & Chief Technology Officer
70
5 Rachel Rodriguez
Vice President of Investor Relations
70
6 Mr. Kirk Kaminsky
President of The US Pharmaceutical & Specialty Solutions Business
70
7 Mr. Pete Slone
Senior Vice President of Corporate Public Affairs
70
8 Ms. Michele Lau
Executive Vice President & Chief Legal Officer
70
9 Ms. LeAnn B. Smith
Executive Vice President & Chief Human Resources Officer
70
10 Mr. Brian S. Tyler Ph.D.
Chief Executive Officer & Director
70

McKesson Corporation Competitors